透過您的圖書館登入
IP:18.118.148.168
  • 學位論文

前列腺素的分解代謝在脂肪細胞分化過程中所扮演的角色

The role of prostaglandin catabolism in adipocyte differentiation.

指導教授 : 張智芬

摘要


3T3-L1 細胞株是一個研究脂肪細胞分化機制最常用的模式系統,本論文中,前列腺素還原酉每(PGR-2)最初是一個利用mRNA差異呈現法(differential display),被篩選出來的一個功能未知的基因;它是一個在3T3-L1 的脂肪細胞分化過程後期高度表現的基因,在組織的分布上,尤其在脂肪組織中具有特別高的表現。經過基因庫序列的比對分析,基因的選殖及其重組蛋白質的表現,酵素活性的測試,以及酵素反應產物的定性分析,從而證實此基因的表現具有催化15-keto prostaglandin E2 (15-keto-PGE2)還原成為13,14-dihydro-15-ketoprostaglandin E2的15-oxoprostaglandin- Δ13-reductase酵素活性,也因此將此基因定名為前列腺素還原酉每(PGR-2)。 前列腺素E2是一個半生期很短的活性小分子,其分解代謝先由 NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (PGDH)進行氧化反應產生15-keto-PGE2,再由NADPH/NADH-dependent 15-oxoprostaglandin-Δ13-reductase(PGR)進一步還原作用將15-keto-PGE2轉變為沒有活性的 13,14-dihydro-15-keto-PGE2。早期的研究發現脂肪組織具有高度的PGDH 與PGR之酵素活性,顯示前列腺素E2分解代謝在脂肪細胞中是旺盛的。 PPAR-γ 是一個在調控脂肪細胞分化上扮演重要角色的轉錄因子,在轉錄因子的分類上,它是屬於nuclear receptor的子家族成員,配體(ligand)對PPAR-γ的結合,使得轉錄輔抑制子從而脫離,並促使轉錄輔活化子返回與PPAR-γ結合,同時PPAR-γ藉由與retinoid X receptor (RXR)形成異二聚體才能進而活化其標的基因。目前臨床上治療糖尿病的藥物thiazolidinedione(TZD),即是一類化學合成的PPAR-γ高親合性配體;過去一些天然的化學分子已被報導為潛在的內生性PPAR-γ的配體,但在生理上這些配體是否確實活化PPAR-γ則仍然沒有定論,有趣的是這些天然的化學分子往往伴隨不同的發炎刺激而產生,這與PPAR-γ日益明朗的抗發炎角色呈現正相關性。前列腺素E2的生成在許多發炎反應中皆會明顯增加,然而其代謝是否與調節PPAR-γ活性有關仍屬未知的議題。 本論文中,在3T3-L1 的細胞分化前期額外表現PGR-2 蛋白質時,脂肪細胞的分化明顯被抑制,但卻不影響分化前期PPAR-γ蛋白質的表現;然後,我進一步發現15-keto-PGE2是一個PPAR-γ的配體,藉由增進PPAR-γ與轉錄輔活化子的結合,而活化PPAR-γ的轉錄功能,使其能有效促進PPAR-γ標的基因的表現,與3T3-L1 的脂肪細胞分化;在293T細胞中,以轉染實驗表現PGR-2 蛋白質,的確能夠抑制15-keto-PGE2所引發的PPAR-γ的轉錄活化,反之,以轉染實驗表現前列腺素脫氫酉每15-hydroxyprostaglandin dehydrogenase (PGDH)蛋白質,使其氧化PGE2成為15-keto-PGE2,的確能夠促進PPAR-γ的轉錄活化。因此,根據以上的研究成果,我們認為細胞內PGE2的分解代謝,在調節PPAR-γ的轉錄活化的機制中,可能扮演一個重要的角色。

並列摘要


3T3-L1 preadipocyte cell line has been used as a model for characterizing the events responsible for adipocyte differentiation. In this thesis, we used differential display to identify a novel gene, encoding prostaglandin reductase designated as PGR-2, in the beginning. Its expression pattern is abundant in adipose tissues and highly up-regulated in the late phase of 3T3-L1 adipocyte differentiation. By functional characterization, we found that PGR-2 is capable of converting 15-keto-PGE2 into 13,14-dihydro-15-keto-PGE2. PGE2, a short lived mediator, is catabolized via an oxidation reaction catalyzed by NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (PGDH) for the generation of 15-keto-PGE2, which is further catabolized by a reduction reaction catalyzed by NADPH/NADH-dependent 15-oxoprostaglandin-Δ13-reductase (PGR). It has been shown that adipose tissue possesses high activity of both PGDH and PGR, indicating that PGE2 catabolism is highly active in adipocytes. Peroxisome proliferator-activated receptor γ (PPAR-γ) plays important roles in adipogenesis. PPAR-γ is a ligand-dependent transcription factor that belongs to the nuclear receptor family, activating the transcription of its target genes as heterodimers with retinoid X receptor (RXR). Upon ligand binding, PPAR-γreleases bound corepressors and recruits coactivator for transcriptional activation. Thiazolidinediones (TZDs) are high-affinity synthetic agonists which have been widely used as insulin-sensitizing agents to treat type 2 diabetes. Several natural substances have been identified as potential endogenous PPAR-γ ligands. To date, their physiological significance and role as true endogenous activators for PPAR-γ have been uncertain. Interestingly, these identified ligands are usually associated with different inflammatory stimuli, which correlate with the anti-inflammatory role of PPAR-γ. The production of prostaglandin E2 (PGE2) is elevated in many inflammatory stimuli. However, little is known about whether the catabolism of PGE2 is associated with modulation of PPAR-γactivity. In this thesis, enforced expression of PGR-2 represses transcriptional activity of PPAR-γand adipocyte differentiation of 3T3-L1 cells. Following these observations, we further found that 15-keto-PGE2, an intermediate metabolite within the PGE2 catabolic pathway, functions as a PPAR-γ ligand, by which it stimulates the differentiation of mouse fibroblasts into adipocytes. In accordance, overexpression of PGDH also increased PGE2-dependent activation of PPAR-γ. Our findings provide new insights into PGE2 catabolism in regulation of PPAR-γactivity.

參考文獻


[1] E.E. Kershaw, J.S. Flier. (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89, 2548-2556.
[2] P. Trayhurn. (2005) Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184, 285-293.
[3] H. Green, M. Meuth. (1974) An established pre-adipose cell line and its differentiation in culture. Cell 3, 127-133.
[5] R. Negrel, P. Grimaldi, G. Ailhaud. (1978) Establishment of a preadipocyte clonal cell line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones. Proc Natl Acad Sci USA 75, 6054-6058.
[6] F.M. Gregoire, C.M. Smas, H.S. Sul. (1998) Understanding adipocyte differentiation. Physiol Rev 78, 783-809.

延伸閱讀